2022 Q4 Form 20-F Financial Statement

#000141057823000809 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $864.3M $4.608B $395.5M
YoY Change 118.49% 174.5% 59.69%
Cost Of Revenue $195.4M $1.200B $155.7M
YoY Change 25.46% 106.41% 12.68%
Gross Profit $668.9M $3.408B $239.8M
YoY Change 178.9% 210.6% 119.02%
Gross Profit Margin 77.39% 73.95% 60.63%
Selling, General & Admin $43.98M $354.1M $10.25M
YoY Change 329.06% 787.31% -8.48%
% of Gross Profit 6.57% 10.39% 4.27%
Research & Development $2.738M $10.04M $1.269M
YoY Change 115.76% 54.6% -15.4%
% of Gross Profit 0.41% 0.29% 0.53%
Depreciation & Amortization $107.1M
YoY Change 38.43%
% of Gross Profit 3.14%
Operating Expenses $45.81M $367.3M $11.74M
YoY Change 290.4% 702.13% 2.04%
Operating Profit $623.1M $3.041B $228.1M
YoY Change 173.16% 189.19% 132.75%
Interest Expense $11.90M $16.26M $1.314M
YoY Change 805.48% -198.74% -116.22%
% of Operating Profit 1.91% 0.53% 0.58%
Other Income/Expense, Net
YoY Change
Pretax Income $635.0M $3.057B $229.4M
YoY Change 176.79% 195.37% 155.18%
Income Tax $108.5M $537.1M $50.39M
% Of Pretax Income 17.09% 17.57% 21.97%
Net Earnings $372.9M $1.860B $141.3M
YoY Change 163.94% 148.35% 94.06%
Net Earnings / Revenue 43.15% 40.36% 35.72%
Basic Earnings Per Share $4.80
Diluted Earnings Per Share $0.95 $4.81 $368.0K
COMMON SHARES
Basic Shares Outstanding 391.0M 379.4M
Diluted Shares Outstanding 386.5M

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.534B $3.534B $1.004B
YoY Change 252.01% 252.01% 1210.74%
Cash & Equivalents $3.520B $3.520B $723.8M
Short-Term Investments $13.93M $13.93M $280.3M
Other Short-Term Assets $53.80M $53.80M $45.27M
YoY Change 18.84% 18.84% -26.03%
Inventory $169.5M $169.5M $327.8M
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $18.00K
Total Short-Term Assets $4.889B $4.889B $1.743B
YoY Change 180.51% 180.51% 866.71%
LONG-TERM ASSETS
Property, Plant & Equipment $2.605B $2.605B $1.559B
YoY Change 67.1% 67.1% 51.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $98.63M $98.63M $41.56M
YoY Change 137.3% 137.3% 34.07%
Total Long-Term Assets $2.704B $2.704B $1.601B
YoY Change 68.92% 68.92% 51.18%
TOTAL ASSETS
Total Short-Term Assets $4.889B $4.889B $1.743B
Total Long-Term Assets $2.704B $2.704B $1.601B
Total Assets $7.593B $7.593B $3.344B
YoY Change 127.09% 127.09% 169.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.6M $102.6M $81.47M
YoY Change 25.89% 25.89% 328.78%
Accrued Expenses $51.50M $51.50M $40.85M
YoY Change 26.07% 42.36% 35.26%
Deferred Revenue $122.0M $203.0M
YoY Change -39.89%
Short-Term Debt $20.69M $20.69M $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $734.8M $734.8M $550.5M
YoY Change 33.49% 33.49% 93.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $213.4M $213.4M $112.6M
YoY Change 89.53% 89.53% 282.98%
Total Long-Term Liabilities $213.4M $213.4M $112.6M
YoY Change 89.53% 89.53% -26.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $734.8M $734.8M $550.5M
Total Long-Term Liabilities $213.4M $213.4M $112.6M
Total Liabilities $2.745B $2.745B $1.182B
YoY Change 132.33% 132.33% 150.36%
SHAREHOLDERS EQUITY
Retained Earnings $2.899B $1.079B
YoY Change 168.65%
Common Stock $2.211B $1.017B
YoY Change 117.46%
Preferred Stock
YoY Change
Treasury Stock (at cost) $126.7M $1.749M
YoY Change 7142.88%
Treasury Stock Shares $14.60M $4.643M
Shareholders Equity $4.848B $4.848B $2.162B
YoY Change
Total Liabilities & Shareholders Equity $7.593B $7.593B $3.344B
YoY Change 127.09% 127.09% 169.85%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income $372.9M $1.860B $141.3M
YoY Change 163.94% 148.35% 94.06%
Depreciation, Depletion And Amortization $107.1M
YoY Change 38.43%
Cash From Operating Activities $769.9M $2.467B -$14.08M
YoY Change -5567.68% 286.07% -110.16%
INVESTING ACTIVITIES
Capital Expenditures $1.205B -$64.38M
YoY Change -337.15% -154.42%
Acquisitions
YoY Change
Other Investing Activities -$398.1M -$1.003B $138.3M
YoY Change -387.92% 266.72% -461.96%
Cash From Investing Activities -$398.1M -$1.003B $73.89M
YoY Change -638.76% 28.34% -293.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.999M 1.473B -5.414M
YoY Change -7.67% 100.06% -94.4%
NET CHANGE
Cash From Operating Activities 769.9M 2.467B -14.08M
Cash From Investing Activities -398.1M -1.003B 73.89M
Cash From Financing Activities -4.999M 1.473B -5.414M
Net Change In Cash 366.7M 2.936B 54.40M
YoY Change 574.16% 394.9% 1331.58%
FREE CASH FLOW
Cash From Operating Activities $769.9M $2.467B -$14.08M
Capital Expenditures $1.205B -$64.38M
Free Cash Flow $1.262B $50.30M
YoY Change 9.97% 147.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
3397000
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
852000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.80
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.34
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.95
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.67
CY2020 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.00
CY2021Q4 us-gaap Inventory Net
InventoryNet
327771000
CY2022Q4 us-gaap Inventory Net
InventoryNet
169517000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
18000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1742980000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4889163000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1559110000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2605195000
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
40741000
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
80330000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1809000
CY2021Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
0
CY2022Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
16864000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
820000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
735000
CY2021Q4 us-gaap Assets
Assets
3343651000
CY2022Q4 us-gaap Assets
Assets
7594096000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.95
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.67
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
81469000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
81875000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
20687000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
202958000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
121992000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
142937000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
230440000
CY2021Q4 dq Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
40848000
CY2022Q4 dq Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
51497000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
10815000
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
8417000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
71472000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
221634000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
550499000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
736542000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
90661000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
153176000
CY2021Q4 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
21935000
CY2022Q4 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
19232000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16726000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
80540000
CY2021Q4 us-gaap Liabilities
Liabilities
679821000
CY2022Q4 us-gaap Liabilities
Liabilities
989490000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
777000
CY2022 dq Increase Decrease In Account Payables
IncreaseDecreaseInAccountPayables
6999000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
377177802
CY2022Q4 dq Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
0.58
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
372534652
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
405620792
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
391023327
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
38000
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
40000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1016855000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2211203000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1079042000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2898843000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
67773000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-176032000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4643150
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
14597465
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1749000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
126678000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2161959000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4807376000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
501871000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1797230000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2663830000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6604606000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3343651000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7594096000
CY2020 us-gaap Revenues
Revenues
675602000
CY2021 us-gaap Revenues
Revenues
1678793000
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.36
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.03
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.80
CY2020 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.00
CY2022Q4 dq Cash And Cash Equivalents
CashAndCashEquivalents
3499488000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
191000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20863000
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
365911000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1131566000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
280251000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
13927000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41684000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52932000
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001477641
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
CY2021 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
CY2022 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-34602
CY2022 dei Entity Registrant Name
EntityRegistrantName
DAQO NEW ENERGY CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
Unit 29
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Huadu Mansion
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
838 Zhangyang Road,
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Shanghai
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
200122
CY2022 dei Entity Address Country
EntityAddressCountry
CN
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
391023327
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
1113
CY2022 dei Auditor Name
AuditorName
Deloitte Touche Tohmatsu Certified Public Accountants LLP
CY2022 dei Auditor Location
AuditorLocation
Shanghai, China
CY2021Q4 dq Cash And Cash Equivalents
CashAndCashEquivalents
723775000
CY2022 us-gaap Revenues
Revenues
4608350000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
441610000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
581585000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1200428000
CY2020 us-gaap Gross Profit
GrossProfit
233992000
CY2021 us-gaap Gross Profit
GrossProfit
1097208000
CY2022 us-gaap Gross Profit
GrossProfit
3407922000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39472000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39904000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
354074000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6856000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6495000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10041000
CY2020 dq Other Operating Income Net
OtherOperatingIncomeNet
191000
CY2021 dq Other Operating Income Net
OtherOperatingIncomeNet
609000
CY2022 dq Other Operating Income Net
OtherOperatingIncomeNet
-3181000
CY2020 us-gaap Operating Expenses
OperatingExpenses
46137000
CY2021 us-gaap Operating Expenses
OperatingExpenses
45790000
CY2022 us-gaap Operating Expenses
OperatingExpenses
367296000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
187855000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
1051418000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
3040626000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-25725000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-20482000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14473000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
680000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
4012000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
1110000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
162130000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1034948000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3056889000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28182000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
170101000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
577247000
CY2020 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
133948000
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
864847000
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2479642000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-141000
CY2020 us-gaap Profit Loss
ProfitLoss
133807000
CY2021 us-gaap Profit Loss
ProfitLoss
864847000
CY2022 us-gaap Profit Loss
ProfitLoss
2479642000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4612000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
115923000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
659841000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
129195000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
748924000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1819801000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355087013
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
369341105
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
379365310
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
375017150
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
383766406
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
386459841
CY2020 us-gaap Profit Loss
ProfitLoss
133807000
CY2021 us-gaap Profit Loss
ProfitLoss
864847000
CY2022 us-gaap Profit Loss
ProfitLoss
2479642000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
48438000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
55045000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-325930000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
48438000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
55045000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-325930000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
182245000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
919892000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2153712000
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6846000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
125808000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
586711000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
175399000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
794084000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1567001000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
567158000
CY2020 us-gaap Profit Loss
ProfitLoss
133807000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
48438000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17908000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2677000
CY2020 dq Adjustments To Additional Paid In Capital Contribution From Related Parties
AdjustmentsToAdditionalPaidInCapitalContributionFromRelatedParties
839000
CY2020 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
28088000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
798915000
CY2021 us-gaap Profit Loss
ProfitLoss
864847000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
55045000
CY2021 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
934918000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10077000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
28000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2663830000
CY2022 us-gaap Profit Loss
ProfitLoss
2479642000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-325930000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
314973000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
995000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
124929000
CY2022 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33762000
CY2022 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1630564000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6604606000
CY2020 us-gaap Profit Loss
ProfitLoss
133807000
CY2021 us-gaap Profit Loss
ProfitLoss
864847000
CY2022 us-gaap Profit Loss
ProfitLoss
2479642000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-141000
CY2020 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
133948000
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
864847000
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2479642000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17908000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
10077000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
307447000
CY2020 us-gaap Depreciation
Depreciation
68686000
CY2021 us-gaap Depreciation
Depreciation
77366000
CY2022 us-gaap Depreciation
Depreciation
107097000
CY2020 dq Increase Decrease In Prepaid Expenses Noncurrent
IncreaseDecreaseInPrepaidExpensesNoncurrent
-693000
CY2021 dq Increase Decrease In Prepaid Expenses Noncurrent
IncreaseDecreaseInPrepaidExpensesNoncurrent
-821000
CY2022 dq Increase Decrease In Prepaid Expenses Noncurrent
IncreaseDecreaseInPrepaidExpensesNoncurrent
-1220000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1103000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2749000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8904000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
1956000
CY2021 dq Fair Value Change Of Short Term Investments
FairValueChangeOfShortTermInvestments
-2407000
CY2022 dq Fair Value Change Of Short Term Investments
FairValueChangeOfShortTermInvestments
-1110000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-616000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4378000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8407000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13000
CY2020 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
-5553000
CY2021 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
360259000
CY2022 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
816238000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6689000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
31556000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14923000
CY2020 dq Increase Decrease In Advance Payments
IncreaseDecreaseInAdvancePayments
6018000
CY2021 dq Increase Decrease In Advance Payments
IncreaseDecreaseInAdvancePayments
-4755000
CY2022 dq Increase Decrease In Advance Payments
IncreaseDecreaseInAdvancePayments
-2341000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5125000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
280187000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-138258000
CY2020 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
94000
CY2021 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-118000
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
4000
CY2020 dq Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-65000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
145000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-62000
CY2020 dq Increase Decrease In Account Payables
IncreaseDecreaseInAccountPayables
4556000
CY2021 dq Increase Decrease In Account Payables
IncreaseDecreaseInAccountPayables
61067000
CY2020 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-54345000
CY2021 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-26068000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16138000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
9727000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
14241000
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
16629000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
47451000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
160058000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3335000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
243695000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3616000
CY2020 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-38000
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
25000
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-124000
CY2020 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-497000
CY2021 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-562000
CY2022 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-1005000
CY2020 dq Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-86000
CY2021 dq Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-83000
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1787000
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-12973000
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-65058000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
209753000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
638989000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2462652000
CY2020 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-50000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
209703000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
638989000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2462652000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
118292000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
498505000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1205330000
CY2021 dq Payments To Acquire Land Use Rights
PaymentsToAcquireLandUseRights
9755000
CY2022 dq Payments To Acquire Land Use Rights
PaymentsToAcquireLandUseRights
45188000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
501441000
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
46192000
CY2021 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
227807000
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
298294000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-118292000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-781894000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-998416000
CY2020 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-195000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-118487000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-781894000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-998416000
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22869000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
13213000
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
47538000
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18133000
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
98573000
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
48822000
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
178752000
CY2020 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
198043000
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
244776000
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
178752000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
580000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2139000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
995000
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
28088000
CY2022 dq Acquisition Of Minority Interest Of Subsidiary
AcquisitionOfMinorityInterestOfSubsidiary
776000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
934960000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
124929000
CY2022 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
33762000
CY2022 dq Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
1630563000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-95471000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
736225000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1472091000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95471000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
736225000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1472091000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7365000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12242000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-139942000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3110000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
605562000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2796385000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
845199000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115294000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118404000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
723966000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118404000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
723966000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3520351000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76596000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
723775000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3499488000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
41808000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
191000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
20863000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118404000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
723966000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3520351000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
24696000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
21158000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
7926000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
12808000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
108099000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
350583000
CY2020 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
73148000
CY2021 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
142937000
CY2022 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
251127000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
198000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
5979000
CY2022 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
4082000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">(c) Use of estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Areas where management uses subjective judgment include, but not limited to, useful lives and residual values of long-lived assets, valuation allowances for deferred tax assets and grant-date fair value of share-based award. The Group bases its estimates on historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.</span></p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">(d) Concentration of credit risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially expose the Group to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, short-term investments and notes receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021 and 2022, all of the Group’s cash, cash equivalents, restricted cash and short-term investments were held by major financial institutions in the PRC and international institutions outside of the PRC which management believes are of high credit ratings and no significant credit risk exists for these accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021 and 2022, notes receivable represents bank acceptance drafts that are non-interest bearing and due within three to twelve months. During the year ended December 31, 2021 and 2022, bank’s acceptance notes were used to collect the payment or settle the payable based on an administrative convenience, given these notes are readily convertible to known amounts of cash. In accordance with the procurement agreements, whether cash or bank acceptance notes to settle the payables is at the Group’s discretion, and this selection does not impact the agreed contractual purchase prices. The Group accounts for the transfer of bank acceptance notes, including endorsing bank’s acceptance notes to suppliers and discounting the notes to other banks, as a sale of financial instrument, and derecognizes the notes receivables accordingly. The Group is not directly involved in the cash exchange based on convenience; therefore the Group still reports corresponding constructive receipts and disbursements as cash flows from operating activities on the consolidated statements of cash flows.</p>
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
200000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
20900000
CY2020 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
CY2021 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2022 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
2000000.0
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
1200000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
293600000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
275200000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
37800000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
203000000.0
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
122000000.0
CY2020 dq Unrestricted Cash Subsidies
UnrestrictedCashSubsidies
500000
CY2021 dq Unrestricted Cash Subsidies
UnrestrictedCashSubsidies
1100000
CY2022 dq Unrestricted Cash Subsidies
UnrestrictedCashSubsidies
3200000
CY2020Q4 dq Government Grants Related To Fixed Assets Noncurrent
GovernmentGrantsRelatedToFixedAssetsNoncurrent
400000
CY2021Q4 dq Government Grants Related To Fixed Assets Noncurrent
GovernmentGrantsRelatedToFixedAssetsNoncurrent
0
CY2022Q4 dq Government Grants Related To Fixed Assets Noncurrent
GovernmentGrantsRelatedToFixedAssetsNoncurrent
0
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17900000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10100000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
315000000.0
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2605195000
CY2020 us-gaap Depreciation
Depreciation
68700000
CY2021 us-gaap Depreciation
Depreciation
77400000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
17908000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
10077000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
314973000
CY2021Q4 us-gaap Asset Reporting Currency Denominated Value
AssetReportingCurrencyDenominatedValue
1002000000.0
CY2022Q4 us-gaap Asset Reporting Currency Denominated Value
AssetReportingCurrencyDenominatedValue
3531900000
CY2022 us-gaap Depreciation
Depreciation
107100000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
108925000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
59780000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
20593000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
12531000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
198253000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
97206000
CY2021Q4 us-gaap Inventory Net
InventoryNet
327771000
CY2022Q4 us-gaap Inventory Net
InventoryNet
169517000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
2000000.0
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1559110000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
293619000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
275168000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
202958000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
121992000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
90661000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
153176000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3700000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5700000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
10000000.0
CY2020Q4 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
58200000
CY2021Q4 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
149500000
CY2022Q4 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
171700000
CY2022Q4 us-gaap Equity Restrictions
EquityRestrictions
3090300000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
103067
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.59
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y29D
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
29436000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
156894000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
500743000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1254000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13207000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
76504000
CY2020 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
28182000
CY2021 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
170101000
CY2022 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
577247000
CY2021Q4 dq Deferred Tax Assets Long Lived Assets Depreciation
DeferredTaxAssetsLongLivedAssetsDepreciation
1546000
CY2022Q4 dq Deferred Tax Assets Long Lived Assets Depreciation
DeferredTaxAssetsLongLivedAssetsDepreciation
2068000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
68000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1781000
CY2021Q4 dq Deferred Tax Assets Donation Expenses
DeferredTaxAssetsDonationExpenses
0
CY2022Q4 dq Deferred Tax Assets Donation Expenses
DeferredTaxAssetsDonationExpenses
66000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
816000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1690000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2430000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5605000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
816000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1060000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1614000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4545000
CY2021Q4 dq Deferred Tax Liabilities Long Lived Assets Depreciation
DeferredTaxLiabilitiesLongLivedAssetsDepreciation
3258000
CY2022Q4 dq Deferred Tax Liabilities Long Lived Assets Depreciation
DeferredTaxLiabilitiesLongLivedAssetsDepreciation
2736000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
621000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
595000
CY2021Q4 dq Deferred Tax Liabilities Dividend Withholding Tax
DeferredTaxLiabilitiesDividendWithholdingTax
14461000
CY2022Q4 dq Deferred Tax Liabilities Dividend Withholding Tax
DeferredTaxLiabilitiesDividendWithholdingTax
79945000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
18340000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
83276000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1809000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
16726000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
80540000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.58
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
735000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
103067
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.59
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
729000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
709000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
816000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-65000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
87000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
316000
CY2020 dq Valuation Allowance Deferred Tax Asset Foreign Exchange Effect
ValuationAllowanceDeferredTaxAssetForeignExchangeEffect
45000
CY2021 dq Valuation Allowance Deferred Tax Asset Foreign Exchange Effect
ValuationAllowanceDeferredTaxAssetForeignExchangeEffect
20000
CY2022 dq Valuation Allowance Deferred Tax Asset Foreign Exchange Effect
ValuationAllowanceDeferredTaxAssetForeignExchangeEffect
-72000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
709000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
816000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1060000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
700000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
800000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1100000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.11
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.10
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.10
CY2020 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.01
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.04
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.01
CY2021 dq Dividend Withholding Tax
DividendWithholdingTax
0.01
CY2022 dq Dividend Withholding Tax
DividendWithholdingTax
0.03
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.17
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.16
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y29D
CY2020 us-gaap Net Income Loss
NetIncomeLoss
129195000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
748924000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1819801000
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
3658000
CY2022 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
386000
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
594301000
CY2022 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
878768000
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
3658000
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
594301000
CY2022 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet
878382000
CY2020 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
132853000
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
1343225000
CY2022 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
2698183000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1775417
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.59
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M26D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.73
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13261000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1672350
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.59
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.74
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
19410000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
735000
CY2020 us-gaap Restricted Stock Expense
RestrictedStockExpense
17900000
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
10100000
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
294800000
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
129336000
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
748924000
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1819801000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-141000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
129195000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
748924000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1819801000
CY2020 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2022 us-gaap Dilutive Securities
DilutiveSecurities
-15432000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
129195000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
748924000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1804369000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355087013
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
369341105
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
379365310
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
375017150
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
383766406
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
386459841
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.36
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.03
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.80
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.80
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.34
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.95
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.67
CY2020 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.00
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.95
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.67
CY2022Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
414300000
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q4 dq Amount Payable As Cash Dividends Inclusive Of Taxes
AmountPayableAsCashDividendsInclusiveOfTaxes
7694626374.0
CY2022Q4 dq Amount Payable As Cash Dividends Inclusive Of Taxes
AmountPayableAsCashDividendsInclusiveOfTaxes
1115566931.7
CY2022 dq Percentage Of Distributable Profit Recorded As Deferred Tax Liability
PercentageOfDistributableProfitRecordedAsDeferredTaxLiability
0.4024
CY2023Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M

Files In Submission

Name View Source Status
dq-20221231_lab.xml Edgar Link unprocessable
0001410578-23-000809-index-headers.html Edgar Link pending
0001410578-23-000809-index.html Edgar Link pending
0001410578-23-000809.txt Edgar Link pending
0001410578-23-000809-xbrl.zip Edgar Link pending
dq-20221231.xsd Edgar Link pending
dq-20221231x20f.htm Edgar Link pending
dq-20221231x20f001.jpg Edgar Link pending
dq-20221231x20f002.jpg Edgar Link pending
dq-20221231x20f004.jpg Edgar Link pending
dq-20221231x20f005.jpg Edgar Link pending
dq-20221231xex12d1.htm Edgar Link pending
dq-20221231xex12d2.htm Edgar Link pending
dq-20221231xex13d1.htm Edgar Link pending
dq-20221231xex13d2.htm Edgar Link pending
dq-20221231xex15d1.htm Edgar Link pending
dq-20221231xex2d2.htm Edgar Link pending
dq-20221231xex4d22.htm Edgar Link pending
dq-20221231xex4d22001.jpg Edgar Link pending
dq-20221231xex4d22006.jpg Edgar Link pending
dq-20221231xex4d22007.jpg Edgar Link pending
dq-20221231xex8d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
dq-20221231_cal.xml Edgar Link unprocessable
dq-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dq-20221231x20f_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dq-20221231_def.xml Edgar Link unprocessable